Deletions in CDKN2A/B are also common in canine histiocytic sarcoma, 62.8%, T-cell lymphoma, 55.6%, and canine fibrosarcoma, 100% [54–56]. The gene discussed is CDKN2A; the disease is T-cell non-Hodgkin lymphoma.